Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide

Adv Mater. 2013 Jul 12;25(26):3605-11. doi: 10.1002/adma.201301046. Epub 2013 May 27.

Abstract

The combination of chemo-thermal therapy is the best strategy to ablate tumors, but how to heat deep tumor tissues effectively without side-damage is a challenge. Here, a systemically delivered nanocarrier is designed with multiple advantages, including superior heat absorption, highly efficient hyperthermia, high drug capacity, specific targeting ability, and molecular imaging, to achieve both high antitumor efficacy and effective amplification of hyperthermia with minimal side effects.

Keywords: MRI; brain tumors; focused ultrasound; magnetic nanographene oxide; targeted chemo-thermal therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy*
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic
  • Drug Carriers / chemistry
  • Drug Carriers / therapeutic use
  • Graphite / chemistry*
  • High-Intensity Focused Ultrasound Ablation / methods*
  • Magnetic Resonance Imaging
  • Magnets / chemistry*
  • Mice
  • Nanostructures / chemistry
  • Nanostructures / therapeutic use*
  • Oxides / chemistry*
  • Polyethylene Glycols / chemistry

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Oxides
  • Polyethylene Glycols
  • Graphite